This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $1,185,750
Does bovine lactoferrin (bLF) improve morbidity-free survival and severe retinopathy in very low birthweight infants? The Lactoferrin Infant Feeding Trial (LIFT).
CIHR · 2016 · Principal investigator
- $524,643
Improving quality of care during transport of sick neonates: A national collaborative partnership for outcome improvement and system enhancement
CIHR · 2012 · Co-investigator
Does bovine lactoferrin (bLF) improve morbidity-free survival and severe retinopathy in very low birthweight infants? The Lactoferrin Infant Feeding Trial (LIFT).
Principal investigators: Asztalos, Elizabeth V; Barrington, Keith J; Lodha, Abhay K; Tarnow-Mordi, William
Keywords: Bovine Lactoferrin; Neonatal Morbidities; Neonatal Survival; Preterm Infants
Improving quality of care during transport of sick neonates: A national collaborative partnership for outcome improvement and system enhancement
Principal investigators: Lee, Kyong-Soon; Whyte, Hilary E; Shah, Prakeshkumar
Keywords: Newborn; Newborn Diseases; Patient Outcomes; Patient Transfer; Prospective Cohort Study; Quality Indicators
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.